Literature DB >> 14402119

Disappearance rate of concentrated proconvertin extracts in congenital and acquired hypoproconvertinemia.

M HOAG, P M AGGELER, A H FOWELL.   

Abstract

Entities:  

Keywords:  HEMORRHAGIC DIATHESIS/metabolism

Mesh：

Substances：

Year:  1960        PMID： 14402119      PMCID： PMC293335          DOI： 10.1172/JCI104068

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  10 in total

1.  [Purification of plasma thromboplastin factor B].

Authors:  P M AGGELER; T H SPAET; S G WHITE; A FOWELL; F JOHNSON
Journal:  Rev Hematol       Date:  1954

2.  A simple, specific one-stage prothrombin assay using Russell's viper venom in cephalin suspension.

Authors:  P HJORT; S I RAPAPORT; P A OWREN
Journal:  J Lab Clin Med       Date:  1955-07

3.  The effect of dicumarol on the transvascular exchange of T-1824-labeled protein in rabbits.

Authors:  T E NELSON; E CASTRONOVA; C HYMAN
Journal:  Circ Res       Date:  1956-05       Impact factor: 17.367

4.  Stuart clotting defect. I. Segregation of an hereditary hemorrhagic state from the heterogeneous group heretofore called stable factor (SPCA, proconvertin, factor VII) deficiency.

Authors:  C HOUGIE; E M BARROW; J B GRAHAM
Journal:  J Clin Invest       Date:  1957-03       Impact factor: 14.808

5.  [Congenital factor VII deficiency; family investigation and physiological studies on factor VII].

Authors:  W H HITZIG; W ZOLLINGER
Journal:  Helv Paediatr Acta       Date:  1958-08

6.  A method for assay of Stuart factor.

Authors:  H S SISE; S M LAVELLE; R BECKER
Journal:  Proc Soc Exp Biol Med       Date:  1957-12

7.  Studies on the turnover rate of stable prothrombin conversion factor in man.

Authors:  P G FRICK
Journal:  Acta Haematol       Date:  1958-01       Impact factor: 2.195

8.  The control of dicumarol therapy and the quantitative determination of prothrombin and proconvertin.

Authors:  P A OWREN; K AAS
Journal:  Scand J Clin Lab Invest       Date:  1951       Impact factor: 1.713

9.  Congenital SPCA deficiency: a hitherto unrecognized coagulation defect with hemorrhage rectified by serum and serum fractions.

Authors:  B ALEXANDER; R GOLDSTEIN; G LANDWEHR; C D COOK
Journal:  J Clin Invest       Date:  1951-06       Impact factor: 14.808

10.  Preparation of a human plasma fraction rich in prothrombin, proconvertin, Stuart factor, and PTC and a study of its activity and toxicity in rabbits and man.

Authors:  P DIDISHEIM; J LOEB; C BLATRIX; J P SOULIER
Journal:  J Lab Clin Med       Date:  1959-02
  10 in total
  3 in total

1.  The survival of factor VIII (antihemophilic globulin) and factor IX (plasma thromboplastin component) in normal humans.

Authors:  E ADELSON; J J RHEINGOLD; O PARKER; M STEINER; J C KIRBY
Journal:  J Clin Invest       Date:  1963-07       Impact factor: 14.808

2.  Congenital factor VII deficiency. A case report.

Authors:  A Girolami; G Cattarozzi; G Mengarda; M Lazzarin
Journal:  Blut       Date:  1973-10

3.  Congenital factor VII deficiency. A report of four new cases.

Authors:  R Zimmermann; G Ehlers; W Ehlers; H von Voss; U Göbel; U Wahn
Journal:  Blut       Date:  1979-02-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.